Cargando…
Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer
INTRODUCTION: Acute generalized exanthematous pustulosis is a type of severe cutaneous drug adverse reaction. While apalutamide is known for its high incidence of cutaneous adverse events, it remains unknown whether acute generalized exanthematous pustulosis can develop during apalutamide treatment....
Autores principales: | Honda, Tomoko, Tohi, Yoichiro, Kaku, Yo, Kimura, Nachino, Kato, Takuma, Haba, Reiji, Dainichi, Teruki, Sugimoto, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626358/ https://www.ncbi.nlm.nih.gov/pubmed/36341202 http://dx.doi.org/10.1002/iju5.12525 |
Ejemplares similares
-
Apalutamide‐associated skin rash in patients with prostate cancer: Histological evaluation by skin biopsy
por: Tohi, Yoichiro, et al.
Publicado: (2021) -
Incidental finding of extramammary Paget's disease during active surveillance for early‐stage prostate cancer in a prostate biopsy
por: Fujiwara, Kengo, et al.
Publicado: (2023) -
Aggressive Prostate Cancer in Patients Treated with Active Surveillance
por: Tohi, Yoichiro, et al.
Publicado: (2023) -
Acute generalized exanthematous pustulosis
por: Helal, Luana Pires, et al.
Publicado: (2015) -
A case of pyelocalyceal diverticulum urothelial carcinoma that was difficult to distinguish from cystic renal cell carcinoma preoperatively
por: Matsuda, Iori, et al.
Publicado: (2021)